筛查原发性醛固酮增多症时醛固酮、肾素及醛固酮与肾素比值的变异性
该回顾性队列研究分析了223例高血压患者(其中162例确诊原发性醛固酮增多症),在未使用干扰药物的情况下,血浆醛固酮浓度、直接肾素浓度及醛固酮与肾素比值的个体内变异系数分别为22-25%和41-42%,变异程度高于检测分析变异,且38%的原发性醛固酮增多症患者至少有一次醛固酮与肾素比值低于一线筛查切点70 pmol/L:mU/L(2.4 ng/dL:mU/L)。
要点
- 原发性醛固酮增多症患者和 non-PA 患者的血浆醛固酮浓度变异系数为22-25%,直接肾素浓度和醛固酮与肾素比值的变异系数为41-42%。
- 62例(38%)确诊原发性醛固酮增多症患者至少有一次醛固酮与肾素比值低于一线筛查切点70 pmol/L:mU/L(2.4 ng/dL:mU/L)。
- 作者认为这些发现支持在排除或进一步检查原发性醛固酮增多症之前至少进行2次醛固酮与肾素比值检测。
核心结论
- 在因原发性醛固酮增多症接受检查的患者中,很大一部分存在血浆醛固酮浓度、直接肾素浓度及由此计算的醛固酮与肾素比值的显著个体内变异。
- 这些发现支持在排除或进一步检查原发性醛固酮增多症之前至少进行2次醛固酮与肾素比值检测。
研究设计与样本
- 回顾性队列研究,纳入因原发性醛固酮增多症接受检查的高血压患者,要求至少2次在未使用干扰药物时的醛固酮与肾素比值检测。
- 研究地点为一家三级中心的内分泌高血压门诊,时间为2017年5月至2021年7月。
- 共分析223例患者,其中女性占55%,中位年龄52岁,162例确诊原发性醛固酮增多症。
主要发现
- 在原发性醛固酮增多症组和非原发性醛固酮增多症组中,血浆醛固酮浓度的样本变异系数均为22-25%,直接肾素浓度和醛固酮与肾素比值的样本变异系数均为41-42%。
- 变异性程度显著高于检测方法的分析变异系数。
- 162例确诊原发性醛固酮增多症患者中,62例(38%)至少有一次醛固酮与肾素比值低于一线筛查切点70 pmol/L:mU/L(2.4 ng/dL:mU/L)。
关键数值与推荐
- 醛固酮与肾素比值的一线筛查切点为70 pmol/L:mU/L(2.4 ng/dL:mU/L)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The plasma aldosterone concentration (PAC), renin, and aldosterone-to-renin ratio (ARR) are used to screen for primary aldosteronism (PA). Substantial intra-individual variability of PAC and ARR using plasma renin activity in the context of usual antihypertensive therapy has been described, but there is no data on ARR variability calculated using direct renin concentration (DRC). OBJECTIVE: To describe the intra-individual variability of PAC, DRC, and ARR in the absence of interfering medications in patients with and without PA. DESIGN: Retrospective cohort study. PATIENTS: Hypertensive patients referred for investigation of PA, with at least 2 ARR measurements while off interfering medications. SETTING: Endocrine hypertension service of a tertiary center, from May 2017 to July 2021. MAIN OUTCOME MEASURES: PAC, DRC, and ARR variability was calculated as coefficient of variation (CV) and percent difference (PD). RESULTS: Analysis of 223 patients (55% female, median age 52 years), including 162 with confirmed PA, demonstrated high variability with a sample CV of 22-25% in the PAC and sample CV of 41% to 42% in the DRC and ARR in both the PA and non-PA groups. The degree of variability was substantially higher than the assays' analytical CV. Sixty-two patients (38%) with PA had at least one ARR below 70 pmol/L:mU/L (2.4 ng/dL:mU/L), a cut-off for first-line screening of PA. CONCLUSIONS: Significant intra-individual variability in PAC, DRC, and hence ARR occurs in a large proportion of patients being investigated for PA. These findings support the need for at least 2 ARR before PA is excluded or further investigated.
引用
- Ng E, Gwini SM, Libianto R, et al. Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism. J Clin Endocrinol Metab. 2022. PMID: 36179243. doi:10.1210/clinem/dgac568
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。